Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
Open-market buys, last 90 days
$29,501
in 3 filings
Open-market sales, last 90 days
$27,505
in 1 filing, $28K under 10b5-1 plans

Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-28 Frankel Stanley Director Purchase +1,000 $6.00 $6K 41,478
2026-06-03 Frankel Stanley Director Grant or award · Restricted Stock Units +20,979 20,979
2026-05-20 Frankel Stanley Director Exercise or conversion +21,000 40,478
2026-05-20 Frankel Stanley Director Exercise or conversion · Restricted Stock Units −21,000 0
2025-12-16 Frankel Stanley Director Purchase +2,700 $4.70 $13K 19,478
2025-09-26 Frankel Stanley Director Purchase +2,700 $4.97 $13K 16,778
2025-06-03 Frankel Stanley Director Grant or award · Restricted Stock Units +21,000 21,000
2025-05-27 Frankel Stanley Director Exercise or conversion +9,826 14,078
2025-05-27 Frankel Stanley Director Exercise or conversion · Restricted Stock Units −9,826 0
2024-06-04 Frankel Stanley Director Grant or award · Restricted Stock Units +9,826 9,826
2024-05-04 Frankel Stanley Director Exercise or conversion +4,202 4,252
2024-05-04 Frankel Stanley Director Exercise or conversion · Restricted Stock Units −4,202 0
2023-05-04 Frankel Stanley Director Grant or award · Restricted Stock Units +126,075 126,075
2022-05-10 Frankel Stanley Director Grant or award · Stock Option (Right to Buy) +156,951 156,951
2021-04-12 Frankel Stanley Director Grant or award · Stock Option (Right to Buy) +63,325 63,325

Page 1 of 1 · 15 trades